-
Citing ‘capacity constraints,’ Novo Nordisk plots global wind-down of human insulin pen production
By Fraiser Kansteiner Nov 14, 2024 2:13pm As sales of Novo Nordisk’s GLP-1 drugs for diabetes and […]
-
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
Researchers at Memorial Sloan Kettering Cancer Center and the National Institutes of Health’s National Cancer Institute said their AI approach was able to identify patients more likely to have objective responses to immune checkpoint inhibitors as well as forecast short- and long-term survival among different cancers. (Getty Images)
-
ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop
A new trend has emerged at this year’s American Society of Clinical Oncology conference: the possibility of replacing decades-old chemotherapy with novel approaches. “We want to be part of that wave,” AbbVie Pedro Valencia, Ph.D., AbbVie’s vice president of solid tumor pipeline strategy and execution, told Fierce Biotech onsite in…
-
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030
KEY POINTS Eli Lilly and Novo Nordisk are leaders in fast-growing therapeutic areas. Both companies have excellent track records of innovations and solid results. Their prospects through 2030 look excellent thanks to some major products.
Who We Are
A cross-functional team of advisors in pharmaceutical industry,
helping your company turn strategic and technical challenges into solutions
Set-up and facilitate outsourcing business
Ensure Compliance all along your journey
Timely Advance Program lifecycle
Optimize financial efficiency
What we can do for you
Procurement
Market Scouting
Supplier Selection
Risk Management
Value Negotiation
Contracting
Business Management
Supplier Relationship Management
Technology Transfer
KPI systems
Cost Optimization
Supply Chain
System and Network Design
Supply Planning
Inventory Management
Waste Reduction
Quality Assurance
GMP Compliance (EMA, FDA)
Auditing Services
Mock Inspections
Submission Readiness
Drug Manufacturing
Asset Strategy
Process Optimization
Investigation Support
OPEX/CAPEX projects
Drug Development
Packaging design and Development
Container and Device Selection
Scale-up and Qual/Val
Contract Testing
Why Pharmadoo ?
- A flexible and on-demand resource model supporting your growth when you need it
- Deep understanding of pharmaceutical supply operations and development services
- Cross-functional team of scientists and engineers
- Facilitated access to CDMO capabilities, stakeholders, with insights on their skills
- Strategic and technical advice to overcome your challenges and achieve your goals
Our Partners
Latest News
Contact Us
A Pharmadoo representative will be in touch with you to understand your need and to evaluate collaboration
Reach Us
Pharmadoo LLC
950 N Michigan Avenue # 4003
60611 Chicago IL – USA
USA +1-312-885-7500
CH +41767205182
Business Hours
Monday – Friday – 9am to 5pm
Saturday – Sunday – Closed
